Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices

Neuroscience Letters

Volumn 363, Issue 1, 2004, Pages 1-5

  Mendiguren, Aitziber ^a   Pineda, Joseba ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Anandamide; Cannabinoids; CB1 receptors; Locus coeruleus; N Methyl D aspartate; Noradrenergic neurons; Single unit extracellular recordings; Slices

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N METHYL DEXTRO ASPARTIC ACID; RIMONABANT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ACTIVITY; CONTROLLED STUDY; LOCUS CERULEUS; MALE; NERVE CELL STIMULATION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SINGLE UNIT ACTIVITY;

ACTION POTENTIALS; ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CYCLOHEXANOLS; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; LOCUS COERULEUS; MALE; MORPHOLINES; N-METHYLASPARTATE; NAPHTHALENES; NEURONS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

EID: 2442624506     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.02.073     Document Type: Article

References (20)

1. Burkey T.H., Quock R.M., Consroe P., Ehlert F.J., Hosohata Y., Roeske W.R., Yamamura H.I. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur. J. Pharmacol. 336:1997;295-298
2. De Petrocellis L., Bisogno T., Maccarrone M., Davis J.B., Finazzi-Agro A., Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276:2001;12856-12863
3. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949
4. Felder C.C., Glass M. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38:1998;179-200
5. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314
6. Gardner E.L., Vorel S.R. Cannabinoid transmission and reward-related events. Neurobiol. Dis. 5:1998;502-533
7. Gifford A.N., Bruneus M., Gatley S.J., Lan R., Makriyannis A., Volkow N.D. Large receptor reserve for cannabinoid actions in the central nervous system. J. Pharmacol. Exp. Ther. 288:1999;478-483
8. Hampson A.J., Bornheim L.M., Scanziani M., Spencer Y.C., Gray A.T., Hansen B.M., Leonoudakis D.J., Bickler P.E. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem. 70:1998;671-676
9. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583
10. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202
11. Jentsch J.D., Andrusiak E., Tran A., Bowers M.B. Jr., Roth R.H. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology. 16:1997;426-432
12. 9-tetrahydrocannabinol- induced increases in dopamine utilization in rat prefrontal cortex. Synapse. 28:1998;21-26
13. 9-tetrahydrocannabinol. Neuropharmacology. 26:1987;55-60
14. Marinelli S., Vaughan C.W., Christie M.J., Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol. 543:2002;531-540
15. 2+ signals in cerebellar granule neurons in culture. J. Neurosci. 19:1999;8765-8777
16. Olpe H.R., Steinmann M.W., Brugger F., Pozza M.F. Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;312-314
17. V.C. Oropeza, J.F. Peoples, K. Mackie, E.J. Van Bockstaele, Ultrastructural analysis of the cannabinoid receptor (CB1) in the rat noradrenergic locus coeruleus (LC) in rat brain, Society for Neuroscience's 31st Annual Meeting, Abstract Viewer/Itinerary Planner (2001): 668.15.
18. Patel S., Hillard C.J. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Res. 963:2003;15-25
19. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066
20. Tokuyama S., Zhu H., Oh S., Ho I.K., Yamamoto T. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem. Int. 39:2001;103-109